The spectrum of molecular defects of the CPY21 gene in the hellenic population: Variable concordance between genotype and phenotype in the different forms of congenital adrenal hyperplasia

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2845-2848

  Dracopoulou Vabouli, M ^a   Maniati Christidi, M ^a   Dacou Voutetakis, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID 21 MONOOXYGENASE;

ADRENAL HYPERPLASIA; ARTICLE; CHROMOSOME ANALYSIS; CHROMOSOME DELETION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENOTYPE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL;

ADRENAL HYPERPLASIA, CONGENITAL; GENE CONVERSION; GENE DELETION; GENE FREQUENCY; GENOTYPE; GREECE; HUMANS; MUTATION; PHENOTYPE; STEROID 21-HYDROXYLASE;

EID: 0034970428     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.6.2845     Document Type: Article

References (25)

1. The adrenal hyperplasias
2. Genetic basis of dndocrine disease. II. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency
3. Genetics, diagnosis and Management of 21-hydroxylase deficiency
4. Structure of human steroid 21-hydroxylase genes
5. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: A pseudogene and a genuine gene
6. Molecular pathology of 21-hydroxylase deficiency
7. Genetic disorders of steroid hormone synthesis and metabolism
8. Steroid 21-hydroxylase deficiency: Two additional mutations in salt-wasting disease and rapid screening of disease-causing mutations
9. Rapid deoxyribonucleic acid analysis by allele specific polymerase chain reaction for detection of mutations in the steroid 21-hydroxylase gene
10. Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
11. Salt-wasting congenital adrenal hyperplasia: Detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction
12. Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: Implications for genetic diagnosis and association with disease manifestation
13. Analysis of steroid 21-hydroxylase gene mutations in the Spanish population
14. Point mutations in Italian patients with classic, non-classic, and cryptic forms of steroid 21-hydroxylase deficiency
15. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: Good correlation in a well defined population
16. Mutations of the steroid 21-hydroxylase gene in an Argentinian population of 36 patients with classical congenital adrenal hyperplasia
17. Salt-wasting congenital adrenal hyperplasia: Detection of mutations in CYP21B gene in a Chilean population
18. Molecular genotyping in Brazilian patients with the classical forms of 21-hydroxylase deficiency
19. Mutation screening in British 21-hydroxylase deficiency families and development of novel microsatellite based approaches to prenatal diagnosis
20. Steroid 21-hydroxylase deficiency: Genotype may not predict phenotype
21. High incidence of molecular defects of the CYP21 gene in patients with premature adrenarche
22. Genotype-phenotype analysis in late onset 21-hydroxylase deficiency in comparison to the classical forms
23. Aldosterone synthesis in patients with salt wasting congenital adrenal hyperplasia (21-hydroxylase deficiency) and complete absence of adrenal 21-hydroxylase (P450 c21)
24. Effects of individual mutations in the P450(c21) pseudogene on the P450(c21) activity and their distribution in the patient genomes of congenital 21-hydroxylase deficiency
25. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from Southern Germany